Safety and efficacy of external beam radiation therapy for non-Hodgkin lymphoma in patients with prior90Y-ibritumomab tiuxetan radioimmunotherapy
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference26 articles.
1. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves
2. The radioresponsiveness of human tumours and the initial slope ofthe cell survival curve
3. Distribution of radiation sensitivities for human tumor cells of specific histological types: Comparison of in vitro to in vivo data
4. Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti- idiotype monoclonal antibodies
5. Radiolabeled Antibody Therapy of Human B Cell Lymphomas
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combination radionuclide therapy: A new paradigm;Nuclear Medicine and Biology;2021-07
2. Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma;Immunotherapy;2018-06
3. Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community setting;Nuclear Medicine and Biology;2016-04
4. External Beam Radiotherapy Followed by 90Y Ibritumomab Tiuxetan in Relapsed or Refractory Bulky Follicular Lymphoma;International Journal of Radiation Oncology*Biology*Physics;2011-03
5. Radioimmunotherapy for B-Cell Non-Hodgkin Lymphoma;Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer;2010-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3